Assignee
SCANDIBIO THERAPEUTICS AB
SE·2 granted patents·3 pending applications·0 citations·filing 2017–2021
Top patents by PatentIndex Score
5 records- 0162US11813236B2Substances for treatment of fatty liver-related conditionsSCANDIBIO THERAPEUTICS AB·Filed 2021·Granted Nov 14, 2023·0 cites·21 claims
- 0256US11141396B2Substances for treatment of fatty liver-related conditionsSCANDIBIO THERAPEUTICS AB·Filed 2017·Granted Oct 12, 2021·0 cites·12 claims
- 0348US2024000737A1Substances for treatment of hyperuricaemiaSCANDIBIO THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0447US2023270704A1Aminoacids for treatment of neurological disordersSCANDIBIO THERAPEUTICS AB·Filed 2021·Application pending·0 cites
- 0542US2022088044A1Substances for treatment of coronavirus infectionSCANDIBIO THERAPEUTICS AB·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →